Beddow Capital Management Inc. Grows Position in Mettler-Toledo International, Inc. $MTD

Beddow Capital Management Inc. raised its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 51.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 2,128 shares of the medical instruments supplier’s stock after purchasing an additional 723 shares during the period. Beddow Capital Management Inc.’s holdings in Mettler-Toledo International were worth $2,500,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Bank of New York Mellon Corp raised its stake in Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after buying an additional 376,419 shares in the last quarter. Norges Bank purchased a new position in shares of Mettler-Toledo International in the 2nd quarter valued at $360,126,000. Alliancebernstein L.P. raised its position in shares of Mettler-Toledo International by 21.6% in the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after acquiring an additional 126,147 shares in the last quarter. PineStone Asset Management Inc. boosted its position in Mettler-Toledo International by 41.9% during the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after purchasing an additional 98,737 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Mettler-Toledo International by 42.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock valued at $361,030,000 after purchasing an additional 90,395 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,394.97 on Friday. The business has a fifty day moving average of $1,402.13 and a 200 day moving average of $1,292.07. The firm has a market capitalization of $28.50 billion, a price-to-earnings ratio of 34.79, a price-to-earnings-growth ratio of 4.59 and a beta of 1.40. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same period last year, the business posted $10.21 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Activity

In related news, CEO Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the completion of the transaction, the chief executive officer directly owned 3,670 shares in the company, valued at $5,367,375. The trade was a 35.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Elisha W. Finney sold 474 shares of the stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total value of $679,512.18. Following the sale, the director directly owned 311 shares in the company, valued at $445,840.27. This represents a 60.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 19,565 shares of company stock valued at $28,683,737 over the last quarter. Insiders own 1.94% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on MTD. Barclays raised their price target on shares of Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a report on Monday, November 10th. Bank of America raised their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Citigroup increased their price objective on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday, November 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday. Finally, JPMorgan Chase & Co. increased their price target on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Five analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $1,424.17.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.